These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 3136790)

  • 1. Effect of valpromide on the pharmacokinetics of carbamazepine-10, 11-epoxide.
    Pisani F; Fazio A; Oteri G; Spina E; Perucca E; Bertilsson L
    Br J Clin Pharmacol; 1988 May; 25(5):611-3. PubMed ID: 3136790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of carbamazepine-10,11-epoxide, an active metabolite of carbamazepine, with valproate: a pharmacokinetic study.
    Pisani F; Caputo M; Fazio A; Oteri G; Russo M; Spina E; Perucca E; Bertilsson L
    Epilepsia; 1990; 31(3):339-42. PubMed ID: 2111769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of human liver microsomal epoxide hydrolase by valproate and valpromide: in vitro/in vivo correlation.
    Kerr BM; Rettie AE; Eddy AC; Loiseau P; Guyot M; Wilensky AJ; Levy RH
    Clin Pharmacol Ther; 1989 Jul; 46(1):82-93. PubMed ID: 2501059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical pharmacology of valpromide.
    Bialer M
    Clin Pharmacokinet; 1991 Feb; 20(2):114-22. PubMed ID: 2029804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sodium valproate and valpromide: differential interactions with carbamazepine in epileptic patients.
    Pisani F; Fazio A; Oteri G; Ruello C; Gitto C; Russo F; Perucca E
    Epilepsia; 1986; 27(5):548-52. PubMed ID: 3093212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impairment of carbamazepine-10, 11-epoxide elimination by valnoctamide, a valpromide isomer, in healthy subjects.
    Pisani F; Fazio A; Artesi C; Oteri G; Spina E; Tomson T; Perucca E
    Br J Clin Pharmacol; 1992 Jul; 34(1):85-7. PubMed ID: 1352988
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of probenecid on the pharmacokinetics of carbamazepine in healthy subjects.
    Kim KA; Oh SO; Park PW; Park JY
    Eur J Clin Pharmacol; 2005 Jun; 61(4):275-80. PubMed ID: 15915352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of valpromide and viloxazine on the elimination of carbamazepine-10,11-epoxide, an active metabolite of carbamazepine.
    Perucca E; Pisani F; Spina E; Oteri G; Fazio A; Bertilsson L
    Pharmacol Res; 1989; 21(1):111-2. PubMed ID: 2498859
    [No Abstract]   [Full Text] [Related]  

  • 9. Carbamazepine-valnoctamide interaction in epileptic patients: in vitro/in vivo correlation.
    Pisani F; Haj-Yehia A; Fazio A; Artesi C; Oteri G; Perucca E; Kroetz DL; Levy RH; Bialer M
    Epilepsia; 1993; 34(5):954-9. PubMed ID: 8104783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A limited sampling method for the estimation of AUC and Cmax of carbamazepine and carbamazepine epoxide following a single and multiple dose of a sustained-release product.
    Mahmood I; Chamberlin N
    Br J Clin Pharmacol; 1998 Mar; 45(3):241-6. PubMed ID: 9517367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Valpromide inhibits human epoxide hydrolase.
    Pacifici GM; Franchi M; Bencini C; Rane A
    Br J Clin Pharmacol; 1986 Sep; 22(3):269-74. PubMed ID: 3094569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors influencing plasma concentrations of carbamazepine and carbamazepine-10,11-epoxide in epileptic children and adults.
    Lanchote VL; Bonato PS; Campos GM; Rodrigues I
    Ther Drug Monit; 1995 Feb; 17(1):47-52. PubMed ID: 7725376
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of phenobarbital on the pharmacokinetics of carbamazepine-10,11-epoxide, an active metabolite of carbamazepine.
    Spina E; Martines C; Fazio A; Trio R; Pisani F; Tomson T
    Ther Drug Monit; 1991 Mar; 13(2):109-12. PubMed ID: 2053116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of sodium valproate on carbamazepine disposition and psychomotor profile in man.
    Macphee GJ; Mitchell JR; Wiseman L; McLellan AR; Park BK; McInnes GT; Brodie MJ
    Br J Clin Pharmacol; 1988 Jan; 25(1):59-66. PubMed ID: 3130892
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors influencing serum levels of carbamazepine and carbamazepine-10,11-epoxide in children.
    Altafullah I; Talwar D; Loewenson R; Olson K; Lockman LA
    Epilepsy Res; 1989; 4(1):72-80. PubMed ID: 2753022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Valproic acid-carbamazepine interaction: is valproic acid a selective inhibitor of epoxide hydrolase?
    Svinarov DA; Pippenger CE
    Ther Drug Monit; 1995 Jun; 17(3):217-20. PubMed ID: 7624916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The mechanism of the carbamazepine-valproate interaction in humans.
    Bernus I; Dickinson RG; Hooper WD; Eadie MJ
    Br J Clin Pharmacol; 1997 Jul; 44(1):21-7. PubMed ID: 9241092
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of epoxide hydrolase by valproic acid in epileptic patients receiving carbamazepine.
    Robbins DK; Wedlund PJ; Kuhn R; Baumann RJ; Levy RH; Chang SL
    Br J Clin Pharmacol; 1990 Jun; 29(6):759-62. PubMed ID: 2116161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single-dose kinetics of an enteric-coated formulation of carbamazepine-10,11-epoxide, an active metabolite of carbamazepine.
    Spina E; Tomson T; Svensson JO; Faigle JW; Bertilsson L
    Ther Drug Monit; 1988; 10(4):382-5. PubMed ID: 3201523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of Piperine on the Metabolism and Pharmacokinetics of Carbamazepine in Healthy Volunteers.
    Bedada SK; Appani R; Boga PK
    Drug Res (Stuttg); 2017 Jan; 67(1):46-51. PubMed ID: 27776366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.